Hims Weight Loss Review: Membership, Medicines and Care
Hims offers an online weight-care membership with medication billed separately if prescribed. Its current lineup includes semaglutide, tirzepatide and orforglipron products; the right comparison is the full recurring price and clinical support for your selected plan.
Current semaglutide offers and total cost
The current Hims page advertises Wegovy pill from $149 monthly and Wegovy pen from $199, with medication prices separate from a required weight-loss membership. The membership is $39 for the first month and automatically renews at $149 monthly. A $149 medicine starting price therefore is not a $149 all-in care price. Dose, offer eligibility and current terms still matter. For the full bill, our GLP-1 Price Check directory helps compare medication and membership costs.
Clinical review and ongoing access
Hims describes online intake, a personalized plan, app tools, nutrition/exercise guidance and messaging access to licensed providers. A prescription is a clinical decision, not a guaranteed 24-hour result. Current stated services do not support a claim of medication-only care, no lifestyle support or universal generalist/brief-consultation quality. For broader online weight-management care, SurpassMD describes its program and assessment process.
Approved formulations and compounds
Wegovy and Ozempic are named semaglutide products with formulation-specific labels and indications. They are not interchangeable with any compounded vial or tablet merely because the name semaglutide appears. FDA’s current notice describes compound-related concerns and recommends use only when needs cannot be met by an approved drug. Current availability must be checked rather than inferred from an old partnership announcement.
Insurance and memberships
The current Hims weight-loss page says insurance is not required. That does not promise reimbursement of a cash membership or prescription. Confirm payment terms and any insurer claim rules in advance. The site separates medication FSA/HSA eligibility from a membership fee it describes as ineligible; individual plan rules govern reimbursement.
Deciding whether the plan fits
Compare the recurring all-in amount, exact drug/formulation, state availability, clinician contact, refill process and cancellation. Brand recognition is not a clinical-quality score; this review has not tested consultation depth, support response or delivery performance.
The current advertised lineup
The current product list includes Wegovy pill/pen, Ozempic pill/pen, Zepbound vial/KwikPen and Foundayo, with other listings and conditions. Availability does not establish the same indication or suitability for each medicine. Do not infer a non-GLP-1 prescription or controlled-drug offering from a generic medication roundup.
Hims and Roman are separate identities
This review concerns Hims. Roman/Ro is a separate provider topic; compare the actual service and terms for each provider.